LianBio Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
LianBio (LIANY) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $34.90 million as of 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2023-03-28
- 2022-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $34.90M.
- 2021-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $49.80M.
- 2021-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $18.10M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2022-12-31 | $34.90M 10-K · filed 2023-03-28 |
| 2021-12-31 | $49.80M 10-K · filed 2022-03-31 |
| 2021-09-30 | $18.10M 10-Q/A · filed 2022-01-10 |